Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $156.32 billion. The enterprise value is $167.82 billion.
| Market Cap | 156.32B |
| Enterprise Value | 167.82B |
Important Dates
The next estimated earnings date is Wednesday, October 22, 2025, before market open.
| Earnings Date | Oct 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.48 billion shares outstanding. The number of shares has increased by 0.78% in one year.
| Current Share Class | 1.48B |
| Shares Outstanding | 1.48B |
| Shares Change (YoY) | +0.78% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 92.93% |
| Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 62.79 and the forward PE ratio is 33.94. BSX's PEG ratio is 2.46.
| PE Ratio | 62.79 |
| Forward PE | 33.94 |
| PS Ratio | 8.42 |
| Forward PS | 7.42 |
| PB Ratio | 6.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 44.86 |
| P/OCF Ratio | 36.48 |
| PEG Ratio | 2.46 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.67, with an EV/FCF ratio of 48.15.
| EV / Earnings | 66.99 |
| EV / Sales | 9.07 |
| EV / EBITDA | 35.67 |
| EV / EBIT | 49.50 |
| EV / FCF | 48.15 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.37 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.50 |
| Debt / FCF | 3.45 |
| Interest Coverage | 10.24 |
Financial Efficiency
Return on equity (ROE) is 11.55% and return on invested capital (ROIC) is 6.40%.
| Return on Equity (ROE) | 11.55% |
| Return on Assets (ROA) | 5.39% |
| Return on Invested Capital (ROIC) | 6.40% |
| Return on Capital Employed (ROCE) | 9.32% |
| Revenue Per Employee | $348,943 |
| Profits Per Employee | $47,264 |
| Employee Count | 53,000 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, BSX has paid $502.00 million in taxes.
| Income Tax | 502.00M |
| Effective Tax Rate | 16.73% |
Stock Price Statistics
The stock price has increased by +32.67% in the last 52 weeks. The beta is 0.66, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +32.67% |
| 50-Day Moving Average | 104.48 |
| 200-Day Moving Average | 99.77 |
| Relative Strength Index (RSI) | 53.49 |
| Average Volume (20 Days) | 5,853,664 |
Short Selling Information
The latest short interest is 18.60 million, so 1.26% of the outstanding shares have been sold short.
| Short Interest | 18.60M |
| Short Previous Month | 19.57M |
| Short % of Shares Out | 1.26% |
| Short % of Float | 1.26% |
| Short Ratio (days to cover) | 2.62 |
Income Statement
In the last 12 months, BSX had revenue of $18.49 billion and earned $2.51 billion in profits. Earnings per share was $1.68.
| Revenue | 18.49B |
| Gross Profit | 12.58B |
| Operating Income | 3.39B |
| Pretax Income | n/a |
| Net Income | 2.51B |
| EBITDA | 4.71B |
| EBIT | 3.39B |
| Earnings Per Share (EPS) | $1.68 |
Balance Sheet
The company has $534.00 million in cash and $12.03 billion in debt, giving a net cash position of -$11.49 billion or -$7.76 per share.
| Cash & Cash Equivalents | 534.00M |
| Total Debt | 12.03B |
| Net Cash | -11.49B |
| Net Cash Per Share | -$7.76 |
| Equity (Book Value) | 22.65B |
| Book Value Per Share | 15.14 |
| Working Capital | 1.93B |
Cash Flow
In the last 12 months, operating cash flow was $4.29 billion and capital expenditures -$800.00 million, giving a free cash flow of $3.49 billion.
| Operating Cash Flow | 4.29B |
| Capital Expenditures | -800.00M |
| Free Cash Flow | 3.49B |
| FCF Per Share | $2.35 |
Margins
Gross margin is 68.04%, with operating and profit margins of 18.33% and 13.55%.
| Gross Margin | 68.04% |
| Operating Margin | 18.33% |
| Pretax Margin | 16.22% |
| Profit Margin | 13.55% |
| EBITDA Margin | 25.44% |
| EBIT Margin | 18.33% |
| FCF Margin | 18.84% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.78% |
| Shareholder Yield | -0.78% |
| Earnings Yield | 1.60% |
| FCF Yield | 2.23% |
Analyst Forecast
The average price target for BSX is $118.32, which is 12.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $118.32 |
| Price Target Difference | 12.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 11.72% |
| EPS Growth Forecast (5Y) | 31.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 5.22 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.22 |
| Piotroski F-Score | 5 |